FAMOTIDINE
NDC 81033-023, FAMOTIDINE, powder, for suspension, from Kesin Pharma Corporation.
- Product NDC
- 81033-023
- Status
- Listed
- Labeler
- Kesin Pharma Corporation
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217137
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/81033-023 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FAMOTIDINE40 mg/5mL
Pharmacologic classes
Histamine H2 Receptor Antagonists [MoA]; Histamine-2 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 81033-023-50 | 81033002350 | 50 mL in 1 BOTTLE (81033-023-50) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/446ca466-a43c-0401-e063-6394a90ac0d1NADAC price for package 81033002350
GET /v1/drugs/nadac/81033002350
Use it
Look up 81033-023 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/81033-023 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 81033-023. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.